The Investigational Drug Steering Committee (IDSC) was established in 2005 to collaborate with the NCI in the design and prioritization of early phase drug development trials carried out within the Experimental Therapeutics Clinical Trials Network (ETCTN).
The IDSC is comprised of the Principal Investigators of the ETCTN Lead Academic Organizations, additional subject matter experts, patient advocates, and NCI staff. View the IDSC member roster as of April 08, 2025.
Contact
For more information, contact NCI CCCT Program Director, Wolf Lindwasser, Ph.D. at wolf.lindwasser@nih.gov.